Cutaneous lymphoma;Kutane lymphome

Hautarzt

Volumn 55, Issue 10, 2004, Pages 1005-1017

  Beyeler, M ^a   Burg, G ^a   Dummer, R ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Bexarotene; Clinical manifestations; Cutaneous lymphoma; EORTC classification; Liposomal doxorubicin

Indexed keywords

ALPHA INTERFERON; BEXAROTENE; CHLORAMBUCIL; CHLORMETHINE; CYCLOPHOSPHAMIDE; DENILEUKIN DIFTITOX; DOXORUBICIN; DOXYCYCLINE; LIPOSOME; METHOTREXATE; PREDNISONE; RECOMBINANT GAMMA INTERFERON; RITUXIMAB; STEROID; TG 1042; VINCRISTINE;

ASTHENIA; B CELL LYMPHOMA; CANCER PALLIATIVE THERAPY; CANCER STAGING; CARDIOTOXICITY; ELASTOLYTIC LYMPHOMA; FOLLICLE MUCINOSIS; GERMINAL CENTER LYMPHOMA; HEADACHE; HISTOPATHOLOGY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; HYPOTHYROIDISM; LARGE CELL LYMPHOMA; LEUKOPENIA; LOW DRUG DOSE; LYMPHOCYTOMA; LYMPHOMATOID PAPULOSIS; MARGINAL ZONE LYMPHOMA; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; MYCOSIS FUNGOIDES; NEUROTOXICITY; NON T NON B CELL LYMPHOMA; PAIN; PROGNOSIS; PRURITUS; PUVA; RASH; REVIEW; SEZARY SYNDROME; SKIN ASSOCIATED LYMPHOID TISSUE LYMPHOMA; SKIN LYMPHOMA; SUBCUTANEOUS PANNICULITIS T LYMPHOCYTE LYMPHOMA; T CELL LYMPHOMA; WORINGER KOLOPP DISEASE;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY; COMBINED MODALITY THERAPY; DIAGNOSIS, DIFFERENTIAL; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, T-CELL, CUTANEOUS; NEOPLASM STAGING; PROGNOSIS; SKIN; SKIN NEOPLASMS;

EID: 6344288695     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-004-0816-2     Document Type: Review

References (12)

1. Bekkenk MW, Geelen FA, van Voorst Vader PC et al. (2000) Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment. Blood 95:3653-3661
2. Burg G, Dummer R, Dommann S et al. (1995) Pathology of cutaneous T-cell lymphoma. Hematol Oncol Clin North Am 9:961-997
3. Dummer R, Kamarashev J, Kempf W et al. (2002) Junctional CDS+ cutaneous lymphomas with non-aggressive clinical behavior: a CDS+ variant of mycosis fungoides? Arch Dermatol 138:199-203
4. Grange F, Bekkenk MW, Wechsler J et al. (2001) Prognostic factors in primary cutaneous large B-cell lymphomas: a European multicenter study. J Clin Oncol 19:3602-3610
5. Kaye FJ, Bunn PJ, Steinberg SM et al. (1989) A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides. N Engl J Med 321:1784-1790
6. Kempf W, Dummer R, Burg G (1999) Approach to lymphoproliferative infiltrates of the skin. The difficult lesions. Am J Clin Pathol 111 [Suppl 1]:S84-93
7. Kerl H, Cerroni L, Fink-Puches R, Wolf IH (2004) Primäre kutane B-Zell-Lymphome. JDDG 7:605-621
8. Petrella T, Dalac S, Maynadie M et al. (1999) CD4+ CD56+ cutaneous neoplasms: a distinct hematological entity? Groupe Francais d'Etude des Lymphomes Cutanes (GFELC). Am J Surg Pathol 23:137-146
9. Stadler R, Otte HG, Luger T et al. (1998) Prospective randomized multicenter clinical trial on the use of interferon-2a plus acitretin versus interferon-2a plus PUVA in patients with cutaneous T-cell lymphoma stages I and II. Blood 92:3578-3581
10. Vonderheid EC, Bernengo MG, Burg G et al. (2002) Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas. J Am Acad Dermatol 46:95-106
11. Willemze R, Kerl H, Sterry W et al. (1997) EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 90:354-371
12. Wollina U, Graefe T, Kaatz M (2001) Pegylated doxorubicin for primary cutaneous T cell lymphoma: a report on ten patients with follow-up. Ann N Y Acad Sci 941:214-216